AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2016

Sep 27, 2016

32227_dirs_2016-09-27_09b024bb-a910-4b1b-8f1d-66e49bd94ce4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-09-23

Reporting Person: ALBITAR MAHER (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-23	Common Stock	S	2800	$8.40	Disposed	60692	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	63492	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000)	200000	Direct

Footnotes

F1: On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.